Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
U.N. Security Council members will open discussions on a U.S.- and Bahrain-supported draft resolution that could lead to sanctions and, ultimately, authorization of force should Iran not cease attacks and threats to commercial shipping in the Strait of Hormuz. The initiative comes as renewed exchanges of fire have tested a fragile truce, and as Was…
IDEXX Laboratories increased its 2026 earnings and revenue guidance, prompting a 3.4% rise in premarket trading to $582. The company raised its full-year EPS range and revenue outlook after reporting first-quarter revenue that exceeded analyst expectations, though shares remain down year-to-date by 16.8% as of Monday’s close.
Francis E. Felber, a director at Citizens Community Bancorp Inc. (NASDAQ: CZWI), has increased his ownership in the company through a direct purchase of common stock. The transaction, reported on May 4, 2026, involved an acquisition of 1,000 shares at $20.60 per share, totaling a value of $20,600. This move follows a period of significant price app…
Foresight Autonomous Holdings Ltd. has signed a non-binding term sheet with VisionWave Holdings, Inc. for a strategic investment and technology integration. VisionWave plans to acquire up to 51% of Foresight's shares in exchange for approximately $17.5 million in stock. The collaboration aims to integrate Foresight’s advanced sensor technologies wi…
Fabrinet reported third quarter revenue of $1.21 billion, topping analyst forecasts by $37 million as telecom demand propelled sales. Despite the beat, shares plunged 12.88% on Thursday after mixed segment performance, supply limitations and modest near-term guidance raised investor concerns. Analysts remain split, with some lifting price targets w…
Victoria's Secret & Co. Board addresses BBRC International Pte Limited's proxy contest led by Brett Blundy after the Board declined his appointment as a director, citing reputational and governance risks. The Board emphasizes the Company’s strong performance under CEO Hillary Super, with significant shareholder returns and commitment to executing t…
Ocugen announced strong 12-month Phase 2 data for its OCU410 treatment for geographic atrophy, showing statistically significant lesion reduction, completed enrollment in its Phase 3 trials for retinitis pigmentosa and Stargardt disease, and raised $115 million through convertible notes extending cash runway into 2028. The company plans multiple bi…
Cummins increased its 2026 revenue growth guidance to 8%-11% from a prior range of 3%-8%, driven by sustained demand for generators linked to data-center expansion and an uptick in North American truck markets. First-quarter revenue climbed to $8.4 billion and EPS was $4.71, including a $1.44 per-share charge tied to the sale of its low-pressure fu…
Birchtech Corp., a leader in specialty activated carbon technologies for air and water purification, has appointed Michael Mioska as its new Chief Financial Officer. Mioska brings over 20 years of finance and audit experience, including recent consulting work with Birchtech. The company expects his leadership will facilitate scaling their platforms…
TruGolf, a Nasdaq-listed company specializing in high-tech golf simulators, has signed a lease for a second flagship TruGolf Links Center location in Farmingdale, New York. This new 6,120 square foot facility will offer premium indoor golf simulators, an upscale restaurant with a full bar, and a multi-sport arcade, aiming to deliver an enhanced 'ea…
Fate Therapeutics announced FT819, its off-the-shelf CAR T-cell therapy candidate for moderate-to-severe systemic lupus erythematosus (SLE), has been selected for the FDA's Chemistry, Manufacturing, and Controls Development and Readiness Pilot (CDRP) Program. Coupled with the existing Regenerative Medicine Advanced Therapy (RMAT) designation, this …
Microbot Medical Inc. announced strong commercial adoption of its LIBERTY Endovascular Robotic System, including by sites involved in the ACCESS-PVI pivotal clinical trial. The company is experiencing increased interest following its full market release and is expanding its global presence, highlighted by participation in the upcoming GEST Conferen…
FibroBiologics, Inc., a clinical-stage biotechnology company, announced the initiation of its clinical trial for CYWC628, an investigational fibroblast-based therapy aimed at treating diabetic foot ulcers (DFUs). The company highlighted the importance of this milestone as it transitions from development to clinical execution. It plans to begin pati…
SAB Biotherapeutics, Inc. will release its first quarter 2026 financial results on May 12, 2026, followed by a conference call and webcast at 8:30 AM ET to discuss the results and provide business updates. The company is a clinical-stage biopharmaceutical firm focused on developing fully human immunoglobulin therapeutics for autoimmune diseases, wi…
AtlasClear Holdings, a financial technology services company listed on NYSE American under the ticker ATCH, will present at the Emerging Growth Conference on May 7, 2026. The presentation will outline the company's progress in scaling its clearing platform, recent operational milestones, and strategy to build a technology-enabled financial infrastr…
BGIN BLOCKCHAIN LIMITED revealed its PortableBTC commemorative prototype miner at the Bitcoin 2026 conference, signaling the company's move into Bitcoin mining hardware development and consumer-oriented mining products under its "Crypto for All" vision. The prototype, powered by the company's BT1 ASIC chip, represents a milestone in BGIN's ASIC des…
IMUNON, Inc., a clinical-stage biotech developing DNA-mediated immunotherapies, announced its Q1 2026 financial results and business update conference call set for May 12, 2026. The company will provide updates on IMNN-001, its lead DNA-based interleukin-12 immunotherapy in Phase 3 trials for advanced ovarian cancer, and report progress on its clin…
Perma-Fix Environmental Services, Inc., a leading provider of nuclear and mixed waste management services, scheduled a conference call on May 6, 2026, to discuss its first quarter 2026 business update. The call will feature the company's executives and be accessible via webcast and telephone.
Chanson International Holding, a China and US-based bakery and beverage products provider listed on Nasdaq under the ticker CHSN, announced a 100-for-1 share consolidation effective May 7, 2026. The consolidation will reduce the total shares outstanding, increase the par value per share, and maintain the current trading symbol under a new CUSIP. Th…
Disc Medicine announced the completion of enrollment in its Phase 3 APOLLO study of bitopertin for erythropoietic protoporphyria, with topline data expected in Q4 2026. Updated Phase 2 data for DISC-0974 in anemia of myelofibrosis will be presented at ASCO, and ongoing studies for DISC-3405 in polycythemia vera and sickle cell disease advance with …
Foremost Clean Energy Ltd. announced results from its 2025 helicopter-borne MobileMT electromagnetic survey and ambient noise tomography survey at its CLK Uranium Property in Saskatchewan's Athabasca Basin. The surveys identified complex conductive anomalies and structural features associated with high-grade uranium mineralization, supporting refin…
CorMedix Therapeutics, a U.S.-based biopharmaceutical company, will release its first quarter 2026 financial results on May 14, 2026, before market open. Along with the earnings release, the company will host a corporate update conference call to provide additional insights on its business and operations.
Palisade Bio announced additional Phase 1a/b data for PALI-2108, a once-daily oral PDE4 inhibitor prodrug selectively activated in the ileum and colon, demonstrating sustained target engagement above IC90, colon-selective pathway modulation, and strong clinical, histologic, and biomarker improvements in ulcerative colitis patients. This supports co…
The Vita Coco Company, a leading better-for-you beverage brand, announced its participation in the Goldman Sachs Global Staples Forum on May 12, 2026. Key executives will hold a fireside chat and webcast to discuss the company's growth and market positioning, highlighting its flagship coconut water and protein-infused water brands.
GSI Technology, an AI and high-performance compute processor company, announced its participation in the upcoming LD Micro 16th Annual Invitational conference. The company will present its groundbreaking Associative Processing Unit (APU) technology and provide updates on progress with key proofs of concept and early deployments, including drone sur…
